Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

6.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in the Tumor Microenvironment and Their Impact on Ovarian Cancer Survival and Therapy.

Current oncology (Toronto, Ont.)·2026
Same author

Immunohistochemical and Molecular Testing for the Diagnosis of Primary Cutaneous Ewing Sarcoma: A Comprehensive Review.

Journal of cutaneous pathology·2025
Same author

MicroRNA Signatures in Serous Ovarian Cancer: A Comparison of Prognostic Marker Targets in African Americans and Caucasians.

Diseases (Basel, Switzerland)·2025
Same author

Role of single-nucleotide polymorphism microarray in the classification of BAP1-inactivated melanocytic tumours.

Histopathology·2025
Same author

Ancillary Tools for the Diagnosis of CIC -Rearranged Sarcoma: A Comprehensive Review.

Journal of cutaneous pathology·2025
Same author

Acantholytic Dyskeratoses of the Vulva: Clinicopathologic Characterization of 16 Cases and Review of the Literature.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·2024

Related Experiment Video

Updated: Jan 30, 2026

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

13.5K

Important Recently Characterized Non-Ewing Small Round Cell Tumors.

Cody S Carter1, Rajiv M Patel2

  • 1Department of Pathology, Michigan Medicine, University of Michigan, 2800 Plymouth Road, Building 35, Ann Arbor, MI 48109, USA.

Surgical Pathology Clinics
|February 3, 2019
PubMed
Summary

Ewing-like sarcomas lacking typical features can now be classified by new molecular discoveries, specifically CIC-DUX4 and BCOR-CCNB3 fusions. These findings help distinguish these rare round cell tumors from other sarcomas.

Keywords:
Atypical Ewing sarcomaBCORCICEwing-like sarcomaNon-Ewing sarcomaRound cell sarcomaSarcomaUndifferentiated sarcoma

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.4K
Characterization of Tumor Cells Using a Medical Wire for Capturing Circulating Tumor Cells: A 3D Approach Based on Immunofluorescence and DNA FISH
10:56

Characterization of Tumor Cells Using a Medical Wire for Capturing Circulating Tumor Cells: A 3D Approach Based on Immunofluorescence and DNA FISH

Published on: December 21, 2017

7.4K

Related Experiment Videos

Last Updated: Jan 30, 2026

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

13.5K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.4K
Characterization of Tumor Cells Using a Medical Wire for Capturing Circulating Tumor Cells: A 3D Approach Based on Immunofluorescence and DNA FISH
10:56

Characterization of Tumor Cells Using a Medical Wire for Capturing Circulating Tumor Cells: A 3D Approach Based on Immunofluorescence and DNA FISH

Published on: December 21, 2017

7.4K

Area of Science:

  • Oncology
  • Molecular Pathology
  • Genetics

Background:

  • Ewing-like sarcomas share morphological features with Ewing sarcoma but lack its characteristic molecular and immunohistochemical markers.
  • These tumors represent a heterogeneous group of round cell sarcomas.
  • Recent advancements have identified specific genetic alterations in a subset of these challenging neoplasms.

Purpose of the Study:

  • To summarize the clinicopathologic and molecular characteristics of CIC-rearranged and BCOR-rearranged sarcomas.
  • To highlight the overlapping and distinguishing features of these entities compared to other round cell sarcomas.
  • To provide an updated classification based on recent molecular findings.

Main Methods:

  • Review of clinicopathologic data from patients with Ewing-like sarcomas.
  • Molecular analysis including detection of gene fusions (CIC-DUX4, BCOR-CCNB3).
  • Immunohistochemical profiling to assess differentiation markers.

Main Results:

  • Identification of CIC-DUX4 and BCOR-CCNB3 fusion genes in a significant proportion of Ewing-like sarcomas.
  • Characterization of distinct clinicopathologic profiles for CIC-rearranged and BCOR-rearranged sarcomas.
  • Demonstration of overlapping features with Ewing sarcoma and other round cell tumors, alongside unique identifiers.

Conclusions:

  • CIC-rearranged and BCOR-rearranged sarcomas represent distinct molecular subtypes within the Ewing-like sarcoma category.
  • Molecular classification is crucial for accurate diagnosis and understanding the biology of these rare tumors.
  • Further research is needed to fully elucidate the clinical implications and therapeutic strategies for these sarcomas.